latest update:
[RxAtlas]

drug summary · 2 NDC codes

Skytrofa 1.8 mg/1

Lonapegsomatropin-tcgd

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status BLA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 147130NDC codes 2application BLA761177RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic nameLonapegsomatropin-tcgd
active ingredientsLONAPEGSOMATROPIN
dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
routeSUBCUTANEOUS
strength1.8 mg/1
marketing statusBLA
DEA schedulenot reported
application numberBLA761177
ATC codenot reported
RxCUInot reported
manufacturerAscendis Pharma Endocrinology, Inc.
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classHuman Growth Hormone [CS]; Recombinant Human Growth Hormone [EPC]

NDC codes

2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
73362-014—
73362001401—

Other Lonapegsomatropin-tcgd products

13 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.

  • Skytrofa .7 mg/1
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Ascendis Pharma Endocrinology, Inc.
  • Skytrofa 1.4 mg/1
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Ascendis Pharma Endocrinology, Inc.
  • Skytrofa 11 mg/1
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Ascendis Pharma Endocrinology, Inc.
  • Skytrofa 13.3 mg/1
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Ascendis Pharma Endocrinology, Inc.
  • Skytrofa 2.1 mg/1
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Ascendis Pharma Endocrinology, Inc.
  • Skytrofa 2.5 mg/1
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Ascendis Pharma Endocrinology, Inc.
  • Skytrofa 3 mg/1
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Ascendis Pharma Endocrinology, Inc.
  • Skytrofa 3.6 mg/1
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Ascendis Pharma Endocrinology, Inc.
  • Skytrofa 4.3 mg/1
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Ascendis Pharma Endocrinology, Inc.
  • Skytrofa 5.2 mg/1
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Ascendis Pharma Endocrinology, Inc.
  • Skytrofa 6.3 mg/1
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Ascendis Pharma Endocrinology, Inc.
  • Skytrofa 7.6 mg/1
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Ascendis Pharma Endocrinology, Inc.

1 more are listed in the drug product index.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.